METUAL Trademark
Trademark Overview
On Friday, April 14, 2017, a trademark application was filed for METUAL with the United States Patent and Trademark Office. The USPTO has given the METUAL trademark a serial number of 87411933. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, November 15, 2024. This trademark is owned by Primetime Life Sciences, LLC. The METUAL trademark is filed in the Computer & Software Services & Scientific Services category with the following description:
Pharmaceutical research and development; Pharmaceutical research services; Research and development in the pharmaceutical and biotechnology fields; Research and development of pharmaceuticals for the treatment of age-related diseases and cancer; Research in the field of pharmaceuticals; Research on machines; Research on the subject of pharmaceuticals; Conducting research and clinical trials for others relating to medical devices and pharmaceuticals in the field of ophthalmology; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Providing medical and scientific research information in the fields of pharmaceuticals and genetics; Technical research in the field of pharmaceutical studies
General Information
| Serial Number | 87411933 |
| Word Mark | METUAL |
| Filing Date | Friday, April 14, 2017 |
| Status | 710 - CANCELLED - SECTION 8 |
| Status Date | Friday, November 15, 2024 |
| Registration Number | 5460476 |
| Registration Date | Tuesday, May 1, 2018 |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, August 29, 2017 |
Trademark Statements
| Goods and Services | Pharmaceutical research and development; Pharmaceutical research services; Research and development in the pharmaceutical and biotechnology fields; Research and development of pharmaceuticals for the treatment of age-related diseases and cancer; Research in the field of pharmaceuticals; Research on machines; Research on the subject of pharmaceuticals; Conducting research and clinical trials for others relating to medical devices and pharmaceuticals in the field of ophthalmology; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Providing medical and scientific research information in the fields of pharmaceuticals and genetics; Technical research in the field of pharmaceutical studies |
Classification Information
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 2 - Sec. 8 - Entire Registration |
| Class Status Date | Friday, November 15, 2024 |
| Primary Code | 042 |
| First Use Anywhere Date | Monday, May 1, 2017 |
| First Use In Commerce Date | Monday, May 1, 2017 |
Trademark Owner History
| Party Name | Primetime Life Sciences, LLC |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | Germantown, MD 20874 |
| Party Name | Primetime Life Sciences, LLC |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | Germantown, MD 20874 |
| Party Name | Primetime Life Sciences, LLC |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | Germantown, MD 20874 |
Trademark Events
| Event Date | Event Description |
| Tuesday, April 18, 2017 | NEW APPLICATION ENTERED |
| Friday, April 21, 2017 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Monday, July 10, 2017 | ASSIGNED TO EXAMINER |
| Friday, July 14, 2017 | EXAMINERS AMENDMENT -WRITTEN |
| Friday, July 14, 2017 | EXAMINERS AMENDMENT E-MAILED |
| Friday, July 14, 2017 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Friday, July 14, 2017 | EXAMINER'S AMENDMENT ENTERED |
| Friday, July 14, 2017 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Sunday, July 23, 2017 | ASSIGNED TO LIE |
| Wednesday, August 9, 2017 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, August 29, 2017 | PUBLISHED FOR OPPOSITION |
| Tuesday, August 29, 2017 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, October 24, 2017 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Thursday, February 22, 2018 | TEAS STATEMENT OF USE RECEIVED |
| Thursday, February 22, 2018 | USE AMENDMENT FILED |
| Monday, March 12, 2018 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| Thursday, March 15, 2018 | STATEMENT OF USE PROCESSING COMPLETE |
| Friday, March 23, 2018 | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
| Saturday, March 24, 2018 | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
| Tuesday, May 1, 2018 | REGISTERED-PRINCIPAL REGISTER |
| Monday, May 1, 2023 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED |
| Friday, November 15, 2024 | CANCELLED SEC. 8 (6-YR) |
